Notch活性定义一种具有独特分子和临床病理特征的常见肝细胞癌亚型
研究利用14基因Notch评分对多套人肝细胞癌(HCC)数据进行分层,发现约30%的HCC具有Notch活性特征,转录上类似胆管癌样HCC,缺乏CTNNB1(β-catenin)激活突变且预后普遍较差;小鼠实验表明肝细胞Notch激活足以在NASH背景下诱导β-catenin失活型HCC,而慢性阻断Notch则导致β-catenin依赖性肿瘤发生。
要点
- 约30%的人HCC具有Notch活性特征,转录上类似胆管癌样HCC,缺乏CTNNB1激活突变且预后普遍较差。
- 肝细胞Notch激活与β-catenin信号及肝脏代谢功能受抑相关,并在NASH中与细胞外基质相互作用增加。
- 在致癌物诱导的HCC小鼠模型中,Notch与β-catenin呈互斥模式;慢性阻断Notch导致β-catenin依赖性肿瘤发生。
核心结论
- Notch活性定义了一种具有独特组织学和预后的HCC分子亚型;慢性肝病中持续的Notch信号可在不获得特定基因组驱动突变的情况下驱动肿瘤形成。
研究设计与样本
- 使用14基因Notch评分对来自多套全面分析数据集的人HCC进行分层,并进行基因集富集分析以比较Notch活性HCC与已发表的HCC亚型特征。
- 从Notch报告小鼠中分选Notch活性肝细胞进行RNA测序,并在结合致癌物与NASH诱导饮食的HCC模型中表征Notch活性肿瘤。
- 利用遗传小鼠模型操纵肝细胞Notch,以研究Notch在NASH驱动肿瘤发生中的充分性和必要性。
主要发现
- 约30%的人HCC具有Notch活性特征,转录上类似胆管癌样HCC,缺乏CTNNB1(β-catenin)激活突变且预后普遍较差。
- 肝细胞中内源性Notch激活与β-catenin信号及肝脏代谢功能受抑相关,并在NASH中与细胞外基质相互作用增加。
- 在NASH小鼠中,组成性肝细胞Notch激活足以诱导β-catenin失活型HCC。
- 在致癌物诱导的HCC中,Notch与β-catenin呈互斥模式;在该小鼠模型中,慢性阻断Notch导致β-catenin依赖性肿瘤发生。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The hepatocyte Notch pathway is a pathogenic factor in non-alcoholic steatohepatitis (NASH)-associated fibrosis, but its role in hepatocellular carcinoma (HCC) is less well defined. Herein, we aimed to characterize the molecular and clinical features of Notch-active human HCC, and to investigate the mechanisms by which Notch affects NASH-driven HCC. METHODS: Using a 14-gene Notch score, we stratified human HCCs from multiple comprehensively profiled datasets. We performed gene set enrichment analyses to compare Notch-active HCCs with published HCC subtype signatures. Next, we sorted Notch-active hepatocytes from Notch reporter mice for RNA sequencing and characterized Notch-active tumors in an HCC model combining a carcinogen and a NASH-inducing diet. We used genetic mouse models to manipulate hepatocyte Notch to investigate the sufficiency and necessity of Notch in NASH-driven tumorigenesis. RESULTS: Notch-active signatures were found in ~30% of human HCCs that transcriptionally resemble cholangiocarcinoma-like HCC, exhibiting a lack of activating CTNNB1 (β-catenin) mutations and a generally poor prognosis. Endogenous Notch activation in hepatocytes is associated with repressed β-catenin signaling and hepatic metabolic functions, in lieu of increased interactions with the extracellular matrix in NASH. Constitutive hepatocyte Notch activation is sufficient to induce β-catenin-inactive HCC in mice with NASH. Notch and β-catenin show a pattern of mutual exclusivity in carcinogen-induced HCC; in this mouse model, chronic blockade of Notch led to β-catenin-dependent tumor development. CONCLUSIONS: Notch activity characterizes a distinct HCC molecular subtype with unique histology and prognosis. Sustained Notch signaling in chronic liver diseases can drive tumor formation without acquiring specific genomic driver mutations. LAY SUMMARY: The Notch signaling pathway is known to be involved in the pathogenesis of liver fibrosis. However, its role in liver cancer has not been well defined. Herein, we show that Notch activity is increased in a subset of liver cancers and is associated with poor outcomes. We also used a mouse model to show that aberrant Notch activity can drive cancer progression in obese mice.
引用
- Zhu C, Ho YJ, Salomao MA, et al. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features. J Hepatol. 2020. PMID: 33038431. doi:10.1016/j.jhep.2020.09.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。